Toshiyuki Hirose

Summary

Affiliation: National Hospital Organization
Country: Japan

Publications

  1. pmc A case of matrix-producing carcinoma of the breast
    Toshiyuki Hirose
    Department of Surgery, Tokushima Breast Care Clinic, 4 7 7, Nakashimada Cho, Tokushima 770 0052, Japan
    World J Surg Oncol 6:60. 2008
  2. ncbi request reprint Chromosomal aneusomy (chr 1, 11, 17) detected by fluorescence in situ hybridization may be a prognostic factor in breast cancer
    Masatsugu Takehisa
    Department of Surgery, National Tokushima Hospital, 1354 Shikizi Kamojima cho, Yoshinogawa, Japan
    Anticancer Res 27:1073-8. 2007
  3. ncbi request reprint A case of perinephric liposarcoma which recurred ten years later from the initial operation
    Shinji Kuratate
    Department of Surgery, Tokushima Prefectural Central Hospital, Tokushima, Japan
    J Med Invest 58:154-8. 2011
  4. ncbi request reprint Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer
    Mitsunori Sasa
    Department of Surgery, Tokushima Breast Care Clinic, Tokushima, Japan
    J Surg Oncol 97:30-4. 2008
  5. pmc Clinical efficacy and problems with CT lymphography in identifying the sentinel node in breast cancer
    Masako Takahashi
    Department of Surgery, Tokushima Breast Care Clinic, 4 7 7, Nakashimada Cho, Tokushima, 770 0052, Japan
    World J Surg Oncol 6:57. 2008
  6. ncbi request reprint False-positives in fine-needle aspiration cytology of breast disease can be reduced with p63 immunostaining--a preliminary report
    Taeko Nagao
    Department of Surgery, National Higashi Tokushima Hospital, Tokushima, Japan
    Anticancer Res 26:4373-7. 2006
  7. ncbi request reprint Lower axillary dissection in breast cancer surgery may be candidate for cases with early breast cancer
    Masatsugu Takehisa
    Department of Surgery, Higashi Tokushima National Hospital, National Hospital Organization, Tokushima, Japan
    J Med Invest 52:74-9. 2005
  8. ncbi request reprint Coexistent poorly-differentiated neuroendocrine cell carcinoma and non-invasive well-differentiated adenocarcinoma in tubulovillous adenoma of the rectum: report of a case
    Shinji Kuratate
    Department of Surgery, Tokushima Prefectural Central Hospitalk, Tokushima, Japan
    J Med Invest 57:338-44. 2010

Collaborators

  • Mitsunori Sasa
  • Akira Tangoku
  • Nobuo Satake
  • Masako Takahashi
  • Shinji Kuratate
  • Taeko Nagao
  • Masatsugu Takehisa
  • Toshiyuki Yagi
  • Ryozo Fujino
  • Yukari Harino
  • Yuji Kaneda
  • Motoya Chikakiyo
  • Masayuki Sumitomo
  • Seiya Saitoh
  • Tadaoki Morimoto
  • Yoshimi Bando
  • Seiya Inoue
  • Nobuya Sano
  • Aiichiro Kajikawa
  • Mitsuteru Yoshida

Detail Information

Publications8

  1. pmc A case of matrix-producing carcinoma of the breast
    Toshiyuki Hirose
    Department of Surgery, Tokushima Breast Care Clinic, 4 7 7, Nakashimada Cho, Tokushima 770 0052, Japan
    World J Surg Oncol 6:60. 2008
    ..Several reports suggested that the tumor cells in MPC might originate from the myoepithelial cells, but others suggested the origin was basal-like cells...
  2. ncbi request reprint Chromosomal aneusomy (chr 1, 11, 17) detected by fluorescence in situ hybridization may be a prognostic factor in breast cancer
    Masatsugu Takehisa
    Department of Surgery, National Tokushima Hospital, 1354 Shikizi Kamojima cho, Yoshinogawa, Japan
    Anticancer Res 27:1073-8. 2007
    ..These results indicate the possibility that aneusomy of chromosomes 1, 11 and 17 can serve as prognostic factors of poor outcome in breast cancer patients...
  3. ncbi request reprint A case of perinephric liposarcoma which recurred ten years later from the initial operation
    Shinji Kuratate
    Department of Surgery, Tokushima Prefectural Central Hospital, Tokushima, Japan
    J Med Invest 58:154-8. 2011
    ..Dedifferentiation, occurring in 15% of the well-differentiated liposarcomas, sometimes may develop later. Long-term detailed follow-up is necessary for well-differentiated liposarcoma...
  4. ncbi request reprint Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer
    Mitsunori Sasa
    Department of Surgery, Tokushima Breast Care Clinic, Tokushima, Japan
    J Surg Oncol 97:30-4. 2008
    ..Ordinarily, clinicopathological testing involves only screening for ER, PgR and Her2, and for this reason the therapeutic approach that is decided for triple-negative disease is usually the same regardless of the subtype...
  5. pmc Clinical efficacy and problems with CT lymphography in identifying the sentinel node in breast cancer
    Masako Takahashi
    Department of Surgery, Tokushima Breast Care Clinic, 4 7 7, Nakashimada Cho, Tokushima, 770 0052, Japan
    World J Surg Oncol 6:57. 2008
    ..However, some institutions are limited to use of a dye-guided method alone. Recently, computed tomographic lymphography (CTLG) employing a nonionic contrast medium has achieved SN identification...
  6. ncbi request reprint False-positives in fine-needle aspiration cytology of breast disease can be reduced with p63 immunostaining--a preliminary report
    Taeko Nagao
    Department of Surgery, National Higashi Tokushima Hospital, Tokushima, Japan
    Anticancer Res 26:4373-7. 2006
    ....
  7. ncbi request reprint Lower axillary dissection in breast cancer surgery may be candidate for cases with early breast cancer
    Masatsugu Takehisa
    Department of Surgery, Higashi Tokushima National Hospital, National Hospital Organization, Tokushima, Japan
    J Med Invest 52:74-9. 2005
    ..These results indicate that lower axillary dissection has the potential to become an effective, standard surgical procedure for breast cancer patients whose preoperative disease stage is Stage I...
  8. ncbi request reprint Coexistent poorly-differentiated neuroendocrine cell carcinoma and non-invasive well-differentiated adenocarcinoma in tubulovillous adenoma of the rectum: report of a case
    Shinji Kuratate
    Department of Surgery, Tokushima Prefectural Central Hospitalk, Tokushima, Japan
    J Med Invest 57:338-44. 2010
    ..They would be evaluated, and effective multimodal therapy for NEC carcinomas should be established...